Michael Muniz, ADS Chief Supply Officer Melanie Montero, ADS Revenue Cycle Leader Walt Meffert, ADS Chief Transformation Officer C-Suite additions include Sean Muniz as Chief Supply Chain Officer ...

A groundbreaking treatment for type 2 diabetes has emerged, offering hope to millions of patients worldwide. This innovative approach combines a novel procedure with medication, potentially ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of Biomedical Engineering at UNIST. They have developed a novel pancreatic islet ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, ... At the heart of this new approach is an innovative process that ... where they establish their own blood supply and ...

AstraZeneca and Bristol-Myers Squibb further expand their ongoing diabetes alliance, following the completion of Bristol-Myers Squibb’s acquisition of Amylin Pharmaceuticals. Bristol-Myers ...

As prescriptions for Ozempic soar, the drug and others like it are still reaching only a fraction of the population who could benefit from taking them — and the limited supply is ...

"FDA expands use of Insulet SmartAdjust technology for automated insulin dosing in adults with Type 2 diabetes. Learn more about this innovative glycemic contro ...

Affecting about 39 million people in the U.S., diabetes can damage the small blood vessels that supply blood to the nerves, leading to poor circulation and foot sores, also called ulcers.

ReShape Lifesciences announced the granting of an international patent for its Diabetes Neuromodulation technology, which combines proprietary vagus nerve modulation with vagal stimulation aimed ...

Around the world, there are half a billion adults living with diabetes, many of whom will develop foot ulcers. Across the United States, 85% of all non-traumatic amputations are directly linked to ...

As prescriptions for Ozempic soar, the drug and others like it are still reaching only a fraction of the population who could benefit from taking them — and the limited supply is ...